Skip to Main Content
Pretzel Therapeutics Pretzel Therapeutics
MenuClose
  • About Us
  • Science & Pipeline
  • Publications and Presentations
  • Join Us
  • News
  • Contact Us

Presentations

A Review of Natural History Studies in Polymerase Gamma (POLG) Disease to Identify Potential Knowledge Gaps and Clinical Trial Endpoints for Future Studies Poster

June 17, 2026

PX578: A First-in-Class POLG Activator to Increase mtDNA for Treatment of Mitochondrial DNA Depletion Syndromes Poster

June 16, 2026
  • About Us
  • Science & Pipeline
  • Publications and Presentations
  • Join Us
  • News
  • Contact Us
  • LinkedIn

© 2026, Pretzel Therapeutics. All rights reserved.

  • Privacy Policy
  • Terms of Service
Pretzel Logomark